Philips and Samsung partner to develop integrated healthcare services
Royal Philips and Samsung Electronics are set to partner to further its set ambition to develop connected devices, utilising one another’s technology to safely access and share information.
The agreement will see Samsung’s ARTIK Smart IoT Platform connect to the Philips HealthSuite Digital Platform and allow Samsung’s ecosystem to link with Philips’ cloud platform.
Healthcare application developers will be able to realise interoperable connected health solutions using integrated data sets and innovative HealthSuite services such as advanced health analytics.
“This collaboration will enable healthcare application developers to focus on the development of innovative applications rather than on the technical integration of devices,” said Dale Wiggins, General Manager Philips HealthSuite Digital Platform at Philips.
“By strengthening our HealthSuite ecosystem with Samsung ARTIK, we will be taking another important step in breaking down the silos in today’s healthcare domain to create a trusted and seamless care experience for both consumers and care professionals.”
“This is an incredibly exciting time in healthcare, as the industry begins to harness the power of data to bring better care to consumers,” commented James Stansberry, Senior Vice President and GM, ARTIK IoT, Samsung Electronics.
- Thriving in uncertain times: 8 things we know for sure in life sciences & healthcare
- AI company Atomwise raises $45mn in Series A funding, attracts the attention of the pharma industry
- Blood pressure sensors have been incorporated into smartphone technology
“Samsung ARTIK-enabled devices and cloud services integrated with Philips HealthSuite can address the growing need for connected health platforms that can safely access, share, and analyse information, helping health systems and providers achieve their goal of delivering better care to consumers, from prevention and detection to diagnosis and treatment.”
The agreement will enable users to deliver new applications and services through Philips’ HealthSuite Digital Platform, encompassing the integration of patient data into Electronic Medical Records, as well as undertake enhanced health analytics. Healthcare application developers working with the Philips HealthSuite Digital Platform will be able to use data from devices connected to Samsung’s SmartThings Cloud to develop new, data-driven connected health solutions.
Such data will also be able to be leveraged from various sources, such as Philips’ own HealthSuite IoT solution which is based on Amazon Web Services IoT. Devices built with Samsung ARTIK secure Systems-on-Modules (SOMs) will also be able to integrate with the HealthSuite Digital Platform.
“Our goal together is to provide better treatment for consumers by arming care professionals with more comprehensive, adequate and timely data that informs their patients' diagnosis and treatment plans,” added Michael Golden, Senior Director of Strategy and Business Development at Samsung IoT.
“The two platforms together provide a complete hardware and cloud services offering to advance health analytics and provide secure, integrated solutions that take on today's most complex health care data problems.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”